BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15258470)

  • 1. Increase in the ratio of mitochondrial Bax/Bcl-XL induces Bax activation in human leukemic K562 cell line.
    Liu FT; Goff LK; Hao JH; Newland AC; Jia L
    Apoptosis; 2004 May; 9(3):377-84. PubMed ID: 15258470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl-XL protects BimEL-induced Bax conformational change and cytochrome C release independent of interacting with Bax or BimEL.
    Yamaguchi H; Wang HG
    J Biol Chem; 2002 Nov; 277(44):41604-12. PubMed ID: 12198137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bax conformational change is a crucial step for PUMA-mediated apoptosis in human leukemia.
    Liu FT; Newland AC; Jia L
    Biochem Biophys Res Commun; 2003 Oct; 310(3):956-62. PubMed ID: 14550297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucosamine sulfate-induced apoptosis in chronic myelogenous leukemia K562 cells is associated with translocation of cathepsin D and downregulation of Bcl-xL.
    Wang Z; Liang R; Huang GS; Piao Y; Zhang YQ; Wang AQ; Dong BX; Feng JL; Yang GR; Guo Y
    Apoptosis; 2006 Oct; 11(10):1851-60. PubMed ID: 16850161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis.
    Desagher S; Osen-Sand A; Nichols A; Eskes R; Montessuit S; Lauper S; Maundrell K; Antonsson B; Martinou JC
    J Cell Biol; 1999 Mar; 144(5):891-901. PubMed ID: 10085289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl-X(L) and calyculin A prevent translocation of Bax to mitochondria during apoptosis.
    Ganju N; Eastman A
    Biochem Biophys Res Commun; 2002 Mar; 291(5):1258-64. PubMed ID: 11883953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trail-induced apoptosis in Type I leukemic cells is not enhanced by overexpression of bax.
    Jia L; Patwari Y; Kelsey SM; Newland AC
    Biochem Biophys Res Commun; 2001 May; 283(5):1037-45. PubMed ID: 11355877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcellular distribution and redistribution of Bcl-2 family proteins in human leukemia cells undergoing apoptosis.
    Jia L; Macey MG; Yin Y; Newland AC; Kelsey SM
    Blood; 1999 Apr; 93(7):2353-9. PubMed ID: 10090946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis.
    Chipuk JE; Kuwana T; Bouchier-Hayes L; Droin NM; Newmeyer DD; Schuler M; Green DR
    Science; 2004 Feb; 303(5660):1010-4. PubMed ID: 14963330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. tBid elicits a conformational alteration in membrane-bound Bcl-2 such that it inhibits Bax pore formation.
    Peng J; Tan C; Roberts GJ; Nikolaeva O; Zhang Z; Lapolla SM; Primorac S; Andrews DW; Lin J
    J Biol Chem; 2006 Nov; 281(47):35802-11. PubMed ID: 17005564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bax-induction alone is sufficient to activate apoptosis cascade in wild-type Bax-bearing K562 cells, and the initiation of apoptosis requires simultaneous caspase activation.
    Kobayashi T; Sawa H; Morikawa J; Ueno S; Katayama N; Zhang W; Shiku H
    Int J Oncol; 2002 Apr; 20(4):723-8. PubMed ID: 11894116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The course of etoposide-induced apoptosis from damage to DNA and p53 activation to mitochondrial release of cytochrome c.
    Karpinich NO; Tafani M; Rothman RJ; Russo MA; Farber JL
    J Biol Chem; 2002 May; 277(19):16547-52. PubMed ID: 11864976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Bid-induced apoptosis by Bcl-2. tBid insertion, Bax translocation, and Bax/Bak oligomerization suppressed.
    Yi X; Yin XM; Dong Z
    J Biol Chem; 2003 May; 278(19):16992-9. PubMed ID: 12624108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptides derived from BH3 domains of Bcl-2 family members: a comparative analysis of inhibition of Bcl-2, Bcl-x(L) and Bax oligomerization, induction of cytochrome c release, and activation of cell death.
    Shangary S; Johnson DE
    Biochemistry; 2002 Jul; 41(30):9485-95. PubMed ID: 12135371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence and helicity requirements for the proapoptotic activity of Bax BH3 peptides.
    Shangary S; Oliver CL; Tillman TS; Cascio M; Johnson DE
    Mol Cancer Ther; 2004 Nov; 3(11):1343-54. PubMed ID: 15542773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bax oligomerization in mitochondrial membranes requires tBid (caspase-8-cleaved Bid) and a mitochondrial protein.
    Roucou X; Montessuit S; Antonsson B; Martinou JC
    Biochem J; 2002 Dec; 368(Pt 3):915-21. PubMed ID: 12193163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl.
    Anto RJ; Mukhopadhyay A; Denning K; Aggarwal BB
    Carcinogenesis; 2002 Jan; 23(1):143-50. PubMed ID: 11756235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cadmium induces apoptotic cell death in WI 38 cells via caspase-dependent Bid cleavage and calpain-mediated mitochondrial Bax cleavage by Bcl-2-independent pathway.
    Oh SH; Lee BH; Lim SC
    Biochem Pharmacol; 2004 Nov; 68(9):1845-55. PubMed ID: 15450950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BAD induces apoptosis in cells over-expressing Bcl-2 or Bcl-xL without loss of mitochondrial membrane potential.
    Schimmer AD; Hedley DW; Pham NA; Chow S; Minden MD
    Leuk Lymphoma; 2001 Jul; 42(3):429-43. PubMed ID: 11699408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational change and mitochondrial translocation of Bax accompany proteasome inhibitor-induced apoptosis of chronic lymphocytic leukemic cells.
    Dewson G; Snowden RT; Almond JB; Dyer MJ; Cohen GM
    Oncogene; 2003 May; 22(17):2643-54. PubMed ID: 12730678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.